Artwork
iconShare
 
Manage episode 377087447 series 3426844
Content provided by Neuroendocrine Cancer Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Neuroendocrine Cancer Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

What are Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)? What makes NEC unique? Can a NET transform to NEC? Dr Nitja Raj from Memorial Sloan Kettering Cancer Center in New York City explains NEC tumor biology and how it guides treatment strategy. She also discusses current clinical trials and research.

For more information, visit LACNETS.org/podcast/24.

For more information, visit NCF.net.

  continue reading

47 episodes